Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Stereotactic Body Radiotherapy”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableNot Yet RecruitingNCT05602974
What this trial is testing

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

Who this might be right for
Hepatocellular CarcinomaNarrow MarginAdjuvant Stereotactic Body Radiotherapy+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 140
Not applicableUnknownNCT02446366
What this trial is testing

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Adenocarcinoma
University of Southern California 24
Not applicableNot Yet RecruitingNCT04996914
What this trial is testing

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
RWTH Aachen University 30
Testing effectiveness (Phase 2)UnknownNCT02461836
What this trial is testing

Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University 513
Testing effectiveness (Phase 2)Active Not RecruitingNCT03875573
What this trial is testing

Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:

Who this might be right for
Luminal B
Jules Bordet Institute 147
Not applicableLooking for participantsNCT07077239
What this trial is testing

Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity

Who this might be right for
Prostate Cancer (CRPC)
Jonsson Comprehensive Cancer Center 200
Not applicableStudy completedNCT02830165
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
Jonsson Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 46
Not applicableWithdrawnNCT02307474
What this trial is testing

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03050554
What this trial is testing

SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Andrew Sharabi 2
Testing effectiveness (Phase 2)Study completedNCT02723331
What this trial is testing

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma
Academic Thoracic Oncology Medical Investigators Consortium 48
Not applicableStudy completedNCT06007118
What this trial is testing

Adjuvant Partial-breast Irradiation Using Stereotactic Body Radiation Therapy

Who this might be right for
Early-stage Breast Cancer
Masaryk Memorial Cancer Institute 85
Very early researchWithdrawnNCT03574220
What this trial is testing

Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01595321
What this trial is testing

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Not applicableStudy completedNCT02516969
What this trial is testing

Surgery With or Without Adjuvant Stereotactic Body Radiotherapy

Who this might be right for
Head and Neck Cancer
David A. Clump, MD, PhD 7
Testing effectiveness (Phase 2)Looking for participantsNCT06313190
What this trial is testing

Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 140
Not applicableLooking for participantsNCT06946238
What this trial is testing

Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F)

Who this might be right for
Breast Cancer
IRCCS San Raffaele 311
Testing effectiveness (Phase 2)Looking for participantsNCT04915508
What this trial is testing

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 102
Not applicableUnknownNCT02433574
What this trial is testing

Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection

Who this might be right for
Non-Small-Cell Lung CancerCarcinoma
Juravinski Cancer Center 20
Load More Results